Jeffrey W. Burris

CIK: 0001484322

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (25.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

INDV

Indivior Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Exercise(M)
Direct
79.9K shares-
INDV
Indivior Pharmaceuticals, Inc.
Mar 3, 2026
Tax Payment(F)
Direct
36K shares at avg. $31.98$1.2M
INDV
Indivior Pharmaceuticals, Inc.
Feb 10, 2026
Award(A)
Direct
26.9K shares-
INDV
Indivior Pharmaceuticals, Inc.
Feb 9, 2026
Award(A)
Performance Stock Units
Direct
104.3K shares-

		Type	Shares	Price		Ownership
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Exercise(M)	79,893	-	$0	Direct
Mar 3, 2026	INDV Indivior Pharmaceuticals, Inc.	Tax Payment(F)	36,032	$31.98	$1,152,303	Direct
Feb 10, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A)	26,897	-	$0	Direct
Feb 9, 2026	INDV Indivior Pharmaceuticals, Inc.	Award(A) Performance Stock Units	104,300	-	-	Direct

1-4 of 4 transactions

About Burris Jeffrey W

Burris Jeffrey W (SEC CIK 0001484322) files insider reports with the SEC as Chief Legal Officer of Indivior Pharmaceuticals, Inc. (INDV).

Signal8 holds 3 ownership filings by Burris Jeffrey W (1 Form 3, 2 Form 4), filed between Jan 7, 2026 and Mar 5, 2026. Those filings report 4 transactions, from Feb 9, 2026 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Burris Jeffrey W's filings is in NORTH CHESTERFIELD, VA.

Recent filings by Burris Jeffrey W

Mar 3, 2026: Option exercise of INDV shares (Form 4, code M).
Mar 3, 2026: Tax withholding of INDV shares (Form 4, code F).
Feb 10, 2026: Grant or award of INDV shares (Form 4, code A).
Feb 9, 2026: Grant or award of INDV derivative securities (Form 4, code A).

Other insiders filing for Indivior Pharmaceuticals, Inc. (INDV)

Anderson Woodrow D, Chief Accounting Officer
Heidbreder Christian, Chief Scientific Officer
Ciaffoni Joseph, Chief Executive Officer
Preblick Ryan, Chief Financial Officer
Thompson Juliet, Director
Humphreys Keith, Director

How to read Form 4 transaction codes